Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05479474 · ClinicalTrials.gov registry record · NA
Platelet Rich Plasma Testis Treatment for Infertile Men
A NA study of Male Infertility and Azoospermia, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05479474 is a NA study of Male Infertility and Azoospermia that is actively recruiting participants, run by Stanford University. The registered enrollment target is 10 participants, below the 557-participant average among 8 other Male Infertility trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05479474, a NA study of Male Infertility and Azoospermia, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.
Conditions Studied
Interventions
- BIOLOGICAL Platelet rich plasma
Study Locations (1)
California
- Stanford Urology Clinic - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-01-18 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05479474
The ClinicalTrials.gov registry entry for NCT05479474 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 557-participant average among 8 other Male Infertility trials with a reported enrollment target (98% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Male Infertility appearing as the primary indexed condition, and to 1 intervention - of which Platelet rich plasma is the first listed.
NCT05479474 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05479474 about?
NCT05479474 is a clinical study titled "Platelet Rich Plasma Testis Treatment for Infertile Men". Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intrates...
What is the current status of trial NCT05479474?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-01-18. Estimated completion is 2026-12-31.
What conditions does trial NCT05479474 study?
This clinical trial studies the following conditions: Male Infertility, Azoospermia, Nonobstructive Azoospermia.
What interventions are being tested in trial NCT05479474?
The interventions under investigation include: Platelet rich plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT05479474?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05479474 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Male Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Semen Testing in Men Beginning Attempts to Conceive
ACTIVE NOT RECRUITING · NA
-
To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles.
ACTIVE NOT RECRUITING · NA
-
Male Infertility and Assisted Reproductive Technologies Research Biobank
RECRUITING
-
SpermQT Prospective Observational Trial
ACTIVE NOT RECRUITING
-
A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers
COMPLETED · Phase 1
-
Small RNA Pathways in Mammalian Gametogenesis
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.